Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins.

Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins. - Amino acids en neurotrophic proteins in psychotic disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31735

Enrollment

100

Registered

2008-02-21

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis schizophrenia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 18-65 psychotic disorder legal competence willing to participate

Exclusion criteria

Exclusion criteria: unable to give informed consent relevant somatic/neurologic disorder cytogenetic aberration

Design outcomes

Primary

Measure	Time frame
The BPRS will be used as primary outcome measure. Secondary outcome measures are the CGI-S and I. A clinical relevant improvement is defined as a reduction of at least 40% on the BPRS total score..	—

Countries

Netherlands

Outcome results